Consumer Retention of Risk Information from Direct-to-Consumer Advertising

被引:0
作者
Donald L. Sullivan
Jon C. Schommer
Stephen W. Birdwell
机构
[1] Ohio Northern University,Pharmacy Practice
[2] Raabe College of Pharmacy,Pharmacy Practice
[3] University of Minnesota,Pharmacy Practice & Administration
[4] The Ohio State University,undefined
来源
Drug information journal : DIJ / Drug Information Association | 1999年 / 33卷 / 1期
关键词
Risk information; direct-to-consumer advertising; DTCA;
D O I
暂无
中图分类号
学科分类号
摘要
The objective of this study was to determine if consumers retain risk information from direct-to-consumer advertising (DTCA). The study design utilized a postgroup only control group design. Study participants were randomly selected from a statewide database of men between the ages of 60–75. These sampling criteria were selected because the ads used in the study were related to Benign Prostatic Hyperplasia (BPH). The 1093 participants were randomly assigned to one of three groups: disease-specific institutional ad group, product-specific ad group, or the control group. Participants in the two treatment groups were sent ads at one-week intervals for three weeks. A self-administered mailed questionnaire was used for data collection and mailed one week after the last ad was sent. The results show there was no statistically significant difference among the three groups regarding the correct answering of any of the risk information questions. A post hoc analysis of the data by whether the respondents indicated they had seen an ad for the product or had used the product in the past, however, yielded different results. Respondents who reported they had seen an ad for the product could have seen the ad from some other media source other than the intervention used in this study. These results show that having seen an ad for the product in the past does increase risk information retention. Past experience in taking the product, however, provides an even greater degree of retention of risk information, but may also provide a false sense of knowledge regarding some types of risk information.
引用
收藏
页码:281 / 289
页数:8
相关论文
共 50 条
[41]   Direct-to-consumer advertising for bleeding disorders: a content analysis and expert evaluation of advertising claims [J].
Abel, G. A. ;
Neufeld, E. J. ;
Sorel, M. ;
Weeks, J. C. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (10) :1680-1684
[42]   Prescription drug coupons: Evolution and need for regulation in direct-to-consumer advertising [J].
Mackey, Tim K. ;
Yagi, Nozomi ;
Liang, Bryan A. .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2014, 10 (03) :588-594
[43]   Taking your medicine? Attitudes toward direct-to-consumer advertising (DTCA) [J].
Ceccoli, Stephen J. ;
Klotz, Robert J. .
SOCIAL SCIENCE JOURNAL, 2013, 50 (04) :501-509
[44]   Attitudes of older Americans toward direct-to-consumer advertising: Predictors of impact [J].
Marinac, JS ;
Godfrey, LA ;
Buchinger, C ;
Sun, C ;
Wooten, J ;
Willsie, SK .
DRUG INFORMATION JOURNAL, 2004, 38 (03) :301-311
[45]   Effect of Direct-to-Consumer Advertising on Asthma Medication Sales and Healthcare Use [J].
Daubresse, Matthew ;
Hutfless, Susan ;
Kim, Yoonsang ;
Kornfield, Rachel ;
Qato, Dima M. ;
Huang, Jidong ;
Miller, Kay ;
Emery, Sherry L. ;
Alexander, G. Caleb .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (01) :40-46
[46]   Strategic change within the pharmaceutical industry: The impact of direct-to-consumer advertising for prescription medicines [J].
Hughes-Morgan M. ;
Kendrick J.L. ;
Morgan F.W. ;
Stoltman J.J. .
International Journal of Information Systems and Change Management, 2010, 4 (03) :246-257
[47]   "See your doctor": the impact of direct-to-consumer advertising on patients with different affliction levels [J].
Liu, Qiang ;
Liu, Hongju ;
Kalwani, Manohar .
MARKETING LETTERS, 2020, 31 (01) :37-48
[48]   Framing genetic risk: trust and credibility markers in online direct-to-consumer advertising for genetic testing [J].
Einsiedel, Edna F. ;
Geransar, Rose .
NEW GENETICS AND SOCIETY, 2009, 28 (04) :339-362
[49]   “See your doctor”: the impact of direct-to-consumer advertising on patients with different affliction levels [J].
Qiang Liu ;
Hongju Liu ;
Manohar Kalwani .
Marketing Letters, 2020, 31 :37-48
[50]   Direct-to-Consumer Prescription Drug Advertising and Patient-Provider Interactions [J].
Sullivan, Helen W. ;
Aikin, Kathryn J. ;
Berktold, Jennifer ;
Stein, Karen L. ;
Hoverman, Victoria J. .
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2020, 33 (02) :279-283